# US 2006/0078981 A1 · Reducing branching and enhancing fragmentation in culturing filamentous microorganisms

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0078981 A1
- Document ID: US20060078981A1
- Status: Published application
- Kind: A1
- Application number: 11/263,000
- Filed: 2005-10-28
- Published: 2006-04-13
- Earliest claimed: 1998-06-26
- Inventors: Gilles van Wezel; Barend Kraal; Rudolf Luiten
- Web page: https://patentgrep.com/patent/US20060078981A1

## CPC

- C07K 14/36: from Actinomyces; from Streptomyces (G)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The invention relates to the field of microorganisms and in particular to the culturing of microorganisms. The invention provides means and methods for enhancing the culturing properties of filamentous microorganisms, in particular filamentous fungi. The means and methods according to the invention comprise reducing branching and/or enhancing the fragmentation of filamentous microorganisms, whereby their liquid culturing properties are improved. In one embodiment, this is achieved by providing the microorganisms with activity capable of enhancing fragmentation and/or reducing branching, such as the activity in which, e.g., Streptomyces griseus is encoded by ssgA.

## Claims

### Claim 1

A method for producing a filamentous bacterium exhibiting reduced branching and fragment septation during growth, said method comprising:
providing a filamentous bacterium, said filamentous bacterium lacking significant endogenous SsgA-activity, with the capability of having or expressing heterologous SsgA-activity, which SsgA-activity, in Streptomyces griseus, is encoded by an ssgA gene having at least the nucleotide sequence of SEQ ID NO: 1.

### Claim 2

A method for producing a filamentous bacterium exhibiting enhanced fragmentation during growth, said method comprising:
providing a filamentous bacterium, wherein said filamentous bacterium lacks significant endogenous SsgA-activity, with the capability of having or expressing heterologous SsgA-activity, which SsgA-activity in Streptomyces griseus is encoded by an ssgA gene having the nucleotide sequence of SEQ ID NO: 1.

### Claim 3 (depends on 1)

The method according to claim 1, wherein said additional SsgA-activity is provided by transfecting or transforming said filamentous bacterium with additional genetic information encoding said additional SsgA-activity.

### Claim 4 (depends on 3)

The method according to claim 3, wherein said additional genetic information comprises an ssgA gene or a derivative or fragment thereof encoding similar SsgA-activity.

### Claim 5 (depends on 4)

The method according to claim 4, wherein said ssgA gene is derived from an actinomycete or a streptomycete.

### Claim 6 (depends on 5)

The method according to claim 5, wherein said gene originates from Streptomyoes griseus, Streptomyces collinus, Streptomyces albus, Streptomyces goldeniensis or Streptomyces netropsis.

### Claim 7 (depends on 3)

The method according to claim 3, wherein said additional genetic information is integrated into the filamentous bacterium's genome.

### Claim 8 (depends on 3)

The method according to claim 3, wherein said additional genetic information is part of an episomal element.

### Claim 9 (depends on 3)

The method according to claim 3, wherein said filamentous bacterium does not have significant endogenous SsgA-activity.

### Claim 10 (depends on 3)

The method according to claim 3, wherein said SsgA-activity is inducible or repressible with a signal.

### Claim 11 (depends on 3)

The method according to claim 3, wherein said filamentous bacterium is an Actinomyces or Streptomyces.

### Claim 12 (depends on 3)

The method according to claim 3, wherein said filamentous bacterium produces an antibiotic or a protein.

### Claim 13 (depends on 12)

The method according to claim 12, wherein said protein is heterologous to said filamentous bacterium.

### Claim 14 (depends on 12)

The method according to claim 12, wherein said protein is expressed from a vector encoding said protein present in said filamentous bacterium.

### Claim 15 (depends on 14)

The method according to claim 14, wherein said protein is secreted by said filamentous bacterium.

### Claim 16 (depends on 3)

A filamentous bacterium produced by the method according claim 3.

### Claim 17 (depends on 16)

The filamentous bacterium of claim 16, wherein said filamentous bacterium is an actinomycete.

### Claim 18 (depends on 15)

A method for producing an antibiotic or a useful protein comprising culturing the filamentous bacterium according to claim 15 in a culture and harvesting said antibiotic or protein from said culture.

### Claim 19 (depends on 18)

The method according to claim 18, wherein said culturing is submerged culture.

### Claim 20 (depends on 2)

The method according to claim 2, wherein said additional SsgA-activity is provided by transfecting or transforming said filamentous bacterium with additional genetic information encoding said additional SsgA-activity.

### Claim 21 (depends on 20)

The method according to claim 20, wherein said additional genetic information comprises an ssgA gene.

### Claim 22 (depends on 21)

The method according to claim 21, wherein said ssgA gene originates from an actinomycete.

### Claim 23 (depends on 21)

The method according to claim 21, wherein said ssgA gene originates from a streptomycete.

### Claim 24 (depends on 23)

The method according to claim 23, wherein said gene is derived from Streptomyoes griseus, Streptomyces collinus, Streptomyces albus, Streptomyces goldeniensis or Streptomyces netropsis.
